Retinal vein occlusion and macular edema – critical evaluation of the clinical value of ranibizumab
Pearse A Keane1, Srinivas R Sadda21NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK; 2Doheny Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USAAbstract: Re...
Guardado en:
Autores principales: | Keane PA, Sadda SR |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1c41e548a2294cf9bff89a21cab9492a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment of macular edema due to retinal vein occlusions
por: Channa R, et al.
Publicado: (2011) -
Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex®) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion
por: Chan A, et al.
Publicado: (2011) -
Comparing bevacizumab and ranibizumab for initial reduction of central macular thickness in patients with retinal vein occlusions
por: Singer MA, et al.
Publicado: (2013) -
Vitrectomy for macular edema due to retinal vein occlusion
por: Kumagai K, et al.
Publicado: (2019) -
Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
por: Udaondo P, et al.
Publicado: (2011)